Lunch & Poster Viewing (Even Numbers) — ASN Events

Lunch & Poster Viewing (Even Numbers) — ASN Events

Lunch & Poster Viewing (Even Numbers)

#NSWCancerConf2023

PI3K pathway inhibition augments PKC inhibitor response in uveal melanoma. (#100)

Sabine Abou Hamad

Discovery of colorectal cancer diagnostic signatures using multi-omics. (#102)

Aziz AAA Alnakli

Deciphering the exosomal RNA cargo involved in pancreatic cancer-related diabetes using transcriptomics: a novel approach for early detection of pancreatic cancer (#104)

Differences in tumour infiltrating immune cells in BRCA1/BRCA2 mutant ovarian and breast cancer to predict response to immunotherapy (#106)

Michelle WY Brown

Novel drug (CRO-67) in commercial pipeline have both anti-tumour and stromal reprogramming capacity (#108)

Alterations in the epigenetic machinery associated with prostate cancer health disparities (#110)

Therapeutic potential of the neurotrophin receptor p75^NTR in glioblastoma multiforme (#112)

Amiee AD Dowdell

CD68 and chemokine CXCL16 expression in a cohort of primary and matched recurrent glioblastoma tumour samples. (#116)

Profiling small and large extracellular vesicles in prostate cancer cell lines using metabolomics for diagnosis and progression risk stratification (#118)

Mahmoud A Hamed

Developing combination therapies with the FACT-inhibitor CBL0137 for diffuse midline glioma (DMG) (#120)

Computational interrogation of telomere length and association with prostate cancer ancestral disparity (#122)

Suppression of the Cystine-Glutamate Transporter SLC7A11/xCT system enhances sensitivity of lung cancer cells to platinum-based drugs. (#124)

Deconstructing a complex microenvironment with geometrically structured microtumours (#126)

Dr Chantel Kopecky

Targeting Fibroblast Growth Factor (FGF)-fusions in previously untreatable cancers. (#128)

Investigation of modified glutamine transport via ASCT2 in Xenopus laevis oocytes. (#130)

The use of Tissue Microarrays in cancer research – the pros and cons. (#136)

Temporal proteomic profiling reveals Nidogen-2 as a new stromal co-target in pancreatic cancer (#138)

Driver or passenger? Investigation of the T1010I MET mutation in a metastatic gastric cancer model (#140)

Ann-Katrin Piper

Elucidating the Potential of DPR2b Aza BODIPY: A Novel Photosensitizer for Enhanced Photodynamic Therapy in Breast Cancer (#142)

RAJSHREE RAJINDRAN NAIR

AhR and SULT1A1 induced bioactivation of highly selective breast cancer targeting molecules (#144)

Jennette A Sakoff

MicroRNA to MicroRNA interactions: miR-21 regulation of miR17~92a cluster in Head & Neck Squamous Cell Carcinoma (#146)

Sarah Stapleton

Robotic-Assisted Radical Prostatectomy on a Patient With Large Mullerian Duct Cyst (#148)

Repurposing pirfenidone in combination with temozolomide for the treatment of glioblastoma (#150)

Mahsa MV Vaez Zadeh

The microbial landscape at the gut mucosa in early-stage bowel polyps. (#152)

Evaluation of novel therapies targeting the p53 and apoptotic pathways in treatment-resistant estrogen receptor-positive breast cancer (#154)

Relationships between tumour microenvironment composition in keratinocyte cancers from organ transplant recipients and clinicopathological parameters (#156)

Catherine Zilberg

Activating the endogenous armoury: anticancer drugs as immunotherapy enablers (#160)

Serum and Tissue Metallomics in Pancreatic Ductal Adenocarcinoma as Potential Diagnostic and Prognostic Biomarkers (#166)

Screen-reading volume using artificial intelligence (AI) in breast cancer screening (#170)

Luke Marinovich

Understanding diagnostic performances of surgical trainees on digital mammograms: A comparison to radiology trainees via BREAST test set (#172)

Epithelial ovarian cancer survival by demographic factors in New South Wales: Analysis of data from The Enduring Cancer Data Linkage program (#174)

Projecting the future Australian epithelial ovarian cancer burden by histological subtype. (#176)

Kirstie McLoughlin

Causal inference and mediation methods in randomised controlled trials: a methodological scoping review (#178)

Alcohol consumption, drinking patterns and cause-specific mortality in an Australian cohort of 180,575 participants aged 45 years and over. (#180)

Embedding equity into routine collection of patient reported measures (#182)

Medical Imaging Simulated Radiation Therapy - improving access to palliative Radiation Therapy in WNSWLHD (#184)

Is that drug listed on the Pharmaceutical Benefits Scheme (PBS)? (#186)

Sharon M Leadbitter

Adapting Radiation Oncology to Rural and Regional communities (#188)

Catherine Osborne

Protocol for a pilot study to explore opportunities to recruit Culturally and Linguistically Diverse participants to research (#190)

Tumour characteristics and outcomes of gastric and oesophageal cancers in culturally and linguistically diverse (CALD) patients treated with curative intent in South Western Sydney (#192)

Building research capacity to enhance care and outcomes for patients with head and neck cancer: The AlliEd Health and Nursing Head And Neck CancEr (ENHANCE) Research Group Experience (#194)

Evaluation of a consumer engagement model used in a cancer research network (#196)

Estimating survival scenarios in patients with advanced oesophageal and gastric (AOG) adenocarcinoma treated with systemic therapy: A systematic review of randomised-controlled trials (RCT). (#198)

Sayeda Dr Naher

A method for correlating preclinical MRI with histopathology using a fiducial marker system (#200)

William S Price

Cost estimation of radiotherapy for local control and overall survival benefit of selected cancers in the pelvic region: Rectal cancers and cervical cancers (#202)

Measuring the environmental impact of robotic surgery: A literature review (#204)

Embracing diversity in engaging the community in clinical trials with ConViCTioN (#206)

Systematic review of methodological conduct and risk of bias of Head and Neck cancer outcome prediction models, with recommendations for clinical practice. (#208)

Are we starting with Normal Skeletal Muscle and Fat mass measures for men commencing Androgen Deprivation Therapy? (#210)

Suzzanna Fettell

Taming the Immune Response: CRISPR Based Knockout of HLA Class I and II to Prevent Allorejection of Off-the-Shelf Chimeric Antigen Receptor T-cells (#214)

Detection of spatially-resolved cell-cell interaction across cancer tissue sections (#216)

Enhanced Diagnostic Efficacy in Breast Radiology Education via Artificial Intelligence: A Preliminary Study (#218)

Phuong D (Yun) Trieu

Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials? (#230)

Factors affecting patient compliance and acceptability of medicinal cannabis use for symptom relief in an Australian cancer care setting (#232)

More than just single nucleotide alterations: Delving into the genome of paediatric cancer predisposition (#234)

Safaa Al Haj Hussein

Encyclopedic tumour analysis based personalised combination regimens improves patient outcomes in advanced and refractory solid cancer (#236)

Joachim Fluhrer

Utilizing multi-omics technologies to examine the potential role of causative pathogens in glioblastoma. (#238)

Bavani Gunasegaran

Informing health system planning for biomarker-based treatment: projections of cancer prevalence to 2042 for key pan-tumour biomarkers (dMMR, MSI, high TMB) (#240)

Integrated single cell analysis of chemical and genetic HDAC inhibition to rationalise treatment for neuroblastoma patients (#242)

Monica Phimmachanh

TIM3-targeting chimeric antigen receptor T-cells for treating acute myeloid leukaemia (#244)

Cancer prehabilitation: research priorities of patients and carers - a qualitative study (#246)

Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer (#248)

An Evaluation of Brain Tumour Information Resources: Current State and Next Steps. (#250)

Survivors of childhood cancer experiences of bullying on return to school and work (#252)

Can interactive online education modules improve family carer engagement in cancer care? Evaluation of the eTRIO program among oncology health professionals, patients, and carers. (#254)

Rebekah Laidsaar-Powell

iCanBlend: Blended psychological therapy for the treatment of anxiety and depression in adult patients with an experience of cancer. (#256)

Kelly F Nunes-Zlotkowski

Do young people who survive cancer, identify as ‘survivors’? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer (#258)

Ursula Sansom-Daly

Caregiver fear of cancer recurrence levels, measures, and associations: a systematic review and meta-analysis (#260)

Patterns of care and outcomes for a clinical cohort of patients with lung cancer (2016-2021): Report on the Embedding Research (and Evidence) in Cancer Healthcare - EnRICH Program (#262)

Screening participant and health service impact of population-based breast density notification in Australia: protocol for a co-designed randomised controlled trial (#266)

Adherence in randomised clinical trials of melanoma early diagnosis: a scoping review. (#268)

Deonna Ackermann

Acceptability of risk-tailored cancer screening in the population: multilevel stakeholder perspectives (#270)

Kate L.A Dunlop

Combining effective interventions to increase bowel cancer screening equitably. (#272)

Stephanie SW Walker

The impact of breast density notification on culturally and linguistically diverse (CALD) women – A systematic review (#274)

Jennifer Isautier

Impact of an Online Risk Prediction Tool for Sentinel Node Positivity on Clinical Decision Making in Melanoma Care: A Mixed Methods Study (#276)

Global radiomic features from mammography for predicting difficult‑to‑interpret normal cases (#278)

Somphone Siviengphanom

Neurofilament Light Chain in Axonal Degeneration in Paclitaxel Induced Peripheral Neurotoxicity (#280)

Masarra MD Al Deleemy

The clinically active PARP inhibitor Olaparib ameliorates Doxorubicin-induced Cardiotoxicity in both in vitro and In vivo model (#282)

Dongqing Kelly Chen

SUppoRting PAtient-centred SurvivorShip (SURPASS) at St Vincent’s Health Network: adaptation and adoption of the ‘My Personal Plan’ prostate cancer survivorship care plan for generic use: A study protocol (#284)

Carfilzomib-induced cardiotoxicity: mechanisms & potential treatments. (#286)

Mechanistic insight of chemotherapy-induced cardiotoxicity: elucidating common pathways for various chemotherapeutic drug classes. (#288)

Conagh C.K. Kelly

Examining the current state of supportive care for colorectal cancer survivors in general practice settings (#290)

Cross-cultural adaptation of the Breast Cancer and Lymphedema Symptom Experience Index (BCLE-SEI) in Hindi (#292)

Vincent Singh Paramanandam

Cross-cultural adaptation of the Breast Cancer and Lymphedema Symptom Experience Index (BCLE-SEI) in Bengali (#294)

Vincent Singh Paramanandam

Change in health-related quality of life after a cancer diagnosis in a large cohort of Australian women. (#296)

Md Mijanur Rahman

Physical activity interventions for cancer survivors in Australian general practice: Realist review (#298)

Matthew Patrio MPS Sugiarto

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines (#300)

Chemotherapies and effects on cardiomyocyte viability: which drugs are directly cardiotoxic? (#302)

Lohis Balachandran

Implementation of a Bone Marrow Sparing Planning Technique for Extended-Field Gynaecological Radiation Therapy (#304)

Anti-Cancerous effect of novel chlorambucil-platinum(IV) prodrugs against triple negative breast cancer cells through multi-mechanistic pathways, including changes in the organization of the microtubule cytoskeleton (#306)

Maria George 1 Elias

Deep QSM - Identification of gold seed fiducial markers for MRI only treatment planning in radiation therapy (#308)

Jonathan Goodwin

Outcome heterogeneity in prehabilitation trials- should we be worried? (#310)

In-vitro evaluation of a ROR1 targeting antibody drug conjugate in high grade serous ovarian cancer (#312)

Inhibition of ATR synergistically enhances cell death in combination with temozolomide, radiation and lomustine in glioblastoma cells (#314)

Mathew Lozinski

The effect of exercise interventions on hospital length of stay and admissions during cancer treatment: a systematic review and meta-analysis (#316)

Atovaquone Radiosensitises Diffuse Midline Gliomas by Inhibiting Mitochondrial Metabolism and Hypoxia (#318)

Faiqa Miss Mudassar

Trends in breast cancer treatment in Australia from 2006 to 2019 (#320)

Using Metabolic ketosis to alter DNA Damage response and Cellular Senescence pathways during chemotherapy in Acute Leukemia patients (#322)

Gayathiri Rajakumar

A case of Immune checkpoint inhibitors related tubulo-interstitial nephritis in a metastatic melanoma patient with multiple immune-related adverse events (#324)

Decision Regret in Patients After Robotic or Laparoscopic Radical Prostatectomy - A Literature Review (#326)

Uncovering the druggable proteome of Paediatric Diffuse Midline Gliomas (DMGs) using a chemoproteomic approach. (#328)